UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bristol-Myers Squibb
BMY
$135B
| $395M | 0.09% |
7,631,467
+1,078,108
| +16% | +$50.6M |
|
227
PUT
Stellantis
STLA
$22B
| $395M | 0.09% |
28,102,850
+3,622,100
| +15% | +$61.6M |
|
228
Kinder Morgan
KMI
$69.9B
| $393M | 0.09% |
17,791,790
+849,123
| +5% | +$17.9M |
|
229
American Electric Power
AEP
$69.9B
| $390M | 0.08% |
3,797,924
-80,559
| -2% | -$7.86M |
|
230
iShares Gold Trust
IAU
$63.3B
| $389M | 0.08% |
7,836,792
-236,426
| -3% | -$11.1M |
|
231
PUT
Broadcom
AVGO
$1.99T
| $388M | 0.08% |
2,249,700
+1,321,700
| +142% | +$212M |
|
232
ASML
ASML
$657B
| $386M | 0.08% |
463,539
+102,421
| +28% | +$91.6M |
|
233
PUT
Newmont
NEM
$103B
| $382M | 0.08% |
7,150,867
+552,162
| +8% | +$27.4M |
|
234
Constellation Energy
CEG
$95.4B
| $382M | 0.08% |
1,469,408
+347,530
| +31% | +$69.1M |
|
235
Vanguard Health Care ETF
VHT
$18.1B
| $380M | 0.08% |
1,348,287
+29,752
| +2% | +$8.26M |
|
236
Medtronic
MDT
$110B
| $376M | 0.08% |
4,177,364
-114,678
| -3% | -$9.65M |
|
237
3M
MMM
$93.6B
| $372M | 0.08% |
2,720,804
+356,762
| +15% | +$43.7M |
|
238
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $371M | 0.08% |
2,897,733
-8,218
| -0.3% | -$1.01M |
|
239
Vanguard FTSE All-World ex-US ETF
VEU
$68B
| $371M | 0.08% |
5,888,347
+23,044
| +0.4% | +$1.39M |
|
240
PUT
UnitedHealth
UNH
$370B
| $370M | 0.08% |
632,400
+191,994
| +44% | +$109M |
|
241
Vertex Pharmaceuticals
VRTX
$122B
| $360M | 0.08% |
774,215
+179,835
| +30% | +$86.4M |
|
242
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $359M | 0.08% |
630,983
+20,767
| +3% | +$11.4M |
|
243
Vistra
VST
$48.3B
| $354M | 0.08% |
2,985,346
+618,904
| +26% | +$52.5M |
|
244
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $352M | 0.08% |
3,518,486
+18,620
| +0.5% | +$1.74M |
|
245
Altria Group
MO
$114B
| $351M | 0.08% |
6,886,030
+555,459
| +9% | +$28.1M |
|
246
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
| $351M | 0.08% |
3,842,193
-75,772
| -2% | -$6.68M |
|
247
VanEck Semiconductor ETF
SMH
$72.3B
| $351M | 0.08% |
1,428,869
-81,745
| -5% | -$19.9M |
|
248
Vanguard Total Bond Market
BND
$158B
| $349M | 0.08% |
4,640,457
+38,654
| +0.8% | +$2.86M |
|
249
Gilead Sciences
GILD
$168B
| $347M | 0.08% |
4,137,923
-358,822
| -8% | -$27.4M |
|
250
PUT
iShares MSCI EAFE ETF
EFA
$79.3B
| $347M | 0.08% |
4,143,800
-1,881,600
| -31% | -$151M |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,838 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,107 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.